An independent federal advisory committee to the CDC recommends
the Pfizer-BioNTech vaccine for people over 16. But state health
leaders say distribution and funding challenges remain.
[vc_row][vc_column][us_carousel post_type="ids" ids="260184, 260250, 107361" orderby="post__in" items_quantity="3" items_layout="11024" columns="3" items_gap="5px" overriding_link="post" breakpoint_1_cols="4" breakpoint_2_cols="3" breakpoint_3_cols="2"][/vc_column][/vc_row]
{
"slotId": "7483666091",
"unitType": "in-article",
"pubId": "pub-9300059770542025"
}
(Image credit: Matthew Horwood/Getty Images)
